Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions

See Locations Near You

Summary

The objective of this study was to prove the bioequivalence of Letrozole Tablet under fasted conditions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

- No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

Exclusion Criteria:

Positive test for HIV, Hepatitis B, or Hepatitis C.
Treatment with known enzyme altering drugs.
History of allergic or adverse response to letrozole or any comparable or similar product.

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

28

Study ID:

NCT01367652

Recruitment Status:

Completed

Sponsor:

Roxane Laboratories

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

PRACS Institute, Ltd.
Fargo North Dakota, 58104, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

28

Study ID:

NCT01367652

Recruitment Status:

Completed

Sponsor:


Roxane Laboratories

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider